Development of the calcium plateau following status epilepticus: role of calcium in epileptogenesis

References

• Delorenzo RJ, Sun DA, Deshpande LS. Cellular mechanisms underlying acquired epilepsy: the calcium hypothesis of the induction and maintainance of epilepsy. Pharmacol. Ther.105(3), 229–266 (2005).
   PubMed Web of Science ®Google Scholar
• Willmore LJ. Post-traumatic epilepsy: cellular mechanisms and implications for treatment. Epilepsia31(Suppl. 3), S67–S73 (1990).
   Google Scholar
• Cavalheiro EA, Leite JP, Bortolotto ZA et al. Long-term effects of pilocarpine in rats: structural damage of the brain triggers kindling and spontaneous recurrent seizures. Epilepsia32(6), 778–782 (1991).
   PubMed Web of Science ®Google Scholar
• Lothman EW, Bertram EH 3rd. Epileptogenic effects of status epilepticus. Epilepsia34(Suppl. 1), S59–S70 (1993).
   PubMedGoogle Scholar
• Hesdorffer DC, Logroscino G, Cascino G, Annegers JF, Hauser WA. Risk of unprovoked seizure after acute symptomatic seizure: effect of status epilepticus. Ann. Neurol.44(6), 908–912 (1998).
   PubMed Web of Science ®Google Scholar
• DeLorenzo RJ, Hauser WA, Towne AR et al. A prospective, population-based epidemiologic study of status epilepticus in Richmond, Virginia. Neurology46(4), 1029–1035 (1996).
   PubMed Web of Science ®Google Scholar
• Hauser WA. Status epilepticus: epidemiologic considerations. Neurology40(5 Suppl. 2), 9–13 (1990).
   PubMed Web of Science ®Google Scholar
• Wasterlain CG, Chen JW. Mechanistic and pharmacologic aspects of status epilepticus and its treatment with new antiepileptic drugs. Epilepsia49(Suppl. 9), 63–73 (2008).
   PubMed Web of Science ®Google Scholar
• DeLorenzo RJ, Pellock JM, Towne AR, Boggs JG. Epidemiology of status epilepticus. J. Clin. Neurophysiol.12(4), 316–325 (1995).
   PubMed Web of Science ®Google Scholar
• Li JM, Chen L, Zhou B, Zhu Y, Zhou D. Convulsive status epilepticus in adults and adolescents of southwest China: mortality, etiology, and predictors of death. Epilepsy Behav.14(1), 146–149 (2009).
   PubMedGoogle Scholar
• Drislane FW. Presentation, evaluation, and treatment of nonconvulsive status epilepticus. Epilepsy Behav.1(5), 301–314 (2000).
   PubMed Web of Science ®Google Scholar
• Fountain NB, Lothman EW. Pathophysiology of status epilepticus. J. Clin. Neurophysiol.12(4), 326–342 (1995).
   PubMedGoogle Scholar
• Deshpande LS, Lou JK, Mian A et al. Time course and mechanism of hippocampal neuronal death in an in vitro model of status epilepticus: role of NMDA receptor activation and NMDA dependent calcium entry. Eur. J. Pharmacol.583(1), 73–83 (2008).
   PubMed Web of Science ®Google Scholar
• Fisher RS. Animal models of the epilepsies. Brain Res. Brain Res. Rev.14(3), 245–278 (1989).
   PubMed Web of Science ®Google Scholar
• McNamara JO, Huang YZ, Leonard AS. Molecular signaling mechanisms underlying epileptogenesis. Sci. STKE2006(356), re12 (2006).
   PubMedGoogle Scholar
• Klitgaard H, Matagne A, Vanneste-Goemaere J, Margineanu DG. Pilocarpine-induced epileptogenesis in the rat: impact of initial duration of status epilepticus on electrophysiological and neuropathological alterations. Epilepsy Res.51(1–2), 93–107 (2002).
   PubMedGoogle Scholar
• Pitkanen A, Kharatishvili I, Karhunen H et al. Epileptogenesis in experimental models. Epilepsia48(Suppl. 2), 13–20 (2007).
   PubMedGoogle Scholar
• Cavalheiro EA. The pilocarpine model of epilepsy. Ital. J. Neurol. Sci.16(1–2), 33–37 (1995).
   PubMedGoogle Scholar
• Sombati S, Delorenzo RJ. Recurrent spontaneous seizure activity in hippocampal neuronal networks in culture. J. Neurophysiol.73(4), 1706–1711 (1995).
   PubMed Web of Science ®Google Scholar
• Deshpande LS, Lou JK, Mian A et al.In vitro status epilepticus but not spontaneous recurrent seizures cause cell death in cultured hippocampal neurons. Epilepsy Res.75(2–3), 171–179 (2007).
   PubMedGoogle Scholar
• DeGiorgio CM, Tomiyasu U, Gott PS, Treiman DM. Hippocampal pyramidal cell loss in human status epilepticus. Epilepsia33(1), 23–27 (1992).
   PubMed Web of Science ®Google Scholar
• Sloviter RS. Status epilepticus-induced neuronal injury and network reorganization. Epilepsia40(Suppl. 1), S34–S39; discussion S40–S31 (1999).
   PubMedGoogle Scholar
• Tsuchida TN, Barkovich AJ, Bollen AW, Hart AP, Ferriero DM. Childhood status epilepticus and excitotoxic neuronal injury. Pediatr. Neurol.36(4), 253–257 (2007).
   PubMedGoogle Scholar
• Pitkanen A. On the way to cure epilepsy. Expert Rev. Neurother.4(6), 917–920 (2004).
   PubMedGoogle Scholar
• Deshpande LS, Sun DA, Sombati S et al. Alterations in neuronal calcium levels are associated with cognitive deficits after traumatic brain injury. Neurosci. Lett.441(1), 115–119 (2008).
   PubMed Web of Science ®Google Scholar
• Sun DA, Deshpande LS, Sombati S et al. Traumatic brain injury causes a long-lasting calcium (Ca2+)-plateau of elevated intracellular Ca levels and altered Ca2+ homeostatic mechanisms in hippocampal neurons surviving brain injury. Eur. J. Neurosci.27(7), 1659–1672 (2008).
   PubMed Web of Science ®Google Scholar
• Sun DA, Sombati S, Blair RE, DeLorenzo RJ. Long-lasting alterations in neuronal calcium homeostasis in an in vitro model of stroke-induced epilepsy. Cell Calcium35(2), 155–163 (2004).
   PubMedGoogle Scholar
• West AE, Chen WG, Dalva MB et al. Calcium regulation of neuronal gene expression. Proc. Natl Acad. Sci. USA98(20), 11024–11031 (2001).
   PubMed Web of Science ®Google Scholar
• Mody I, MacDonald JF. NMDA receptor-dependent excitotoxicity: the role of intracellular Ca2+ release. Trends Pharmacol. Sci.16(10), 356–359 (1995).
   PubMed Web of Science ®Google Scholar
• Malenka RC, Nicoll RA. Long-term potentiation – a decade of progress? Science285(5435), 1870–1874 (1999).
   PubMed Web of Science ®Google Scholar
• Choi DW, Maulucci-Gedde M, Kriegstein AR. Glutamate neurotoxicity in cortical cell culture. J. Neurosci.7(2), 357–368 (1987).
   PubMed Web of Science ®Google Scholar
• Raza M, Blair RE, Sombati S et al. Evidence that injury-induced changes in hippocampal neuronal calcium dynamics during epileptogenesis cause acquired epilepsy. Proc. Natl Acad. Sci. USA101(50), 17522–17527 (2004).
   PubMed Web of Science ®Google Scholar
• Pal S, Sombati S, Limbrick DD Jr, DeLorenzo RJ. In vitro status epilepticus causes sustained elevation of intracellular calcium levels in hippocampal neurons. Brain Res.851(1–2), 20–31 (1999).
   PubMedGoogle Scholar
• Sun DA, Sombati S, Blair RE, DeLorenzo RJ. Calcium-dependent epileptogenesis in an in vitro model of stroke-induced “epilepsy”. Epilepsia43(11), 1296–1305 (2002).
   PubMedGoogle Scholar
• Raza M, Pal S, Rafiq A, DeLorenzo RJ. Long-term alteration of calcium homeostatic mechanisms in the pilocarpine model of temporal lobe epilepsy. Brain Res.903(1–2), 1–12 (2001).
   PubMed Web of Science ®Google Scholar
• DeLorenzo RJ, Pal S, Sombati S. Prolonged activation of the N-methyl-D-aspartate receptor-Ca2+ transduction pathway causes spontaneous recurrent epileptiform discharges in hippocampal neurons in culture. Proc. Natl Acad. Sci. USA95(24), 14482–14487 (1998).
   PubMedGoogle Scholar
• Pal S, Sun D, Limbrick D, Rafiq A, DeLorenzo RJ. Epileptogenesis induces long-term alterations in intracellular calcium release and sequestration mechanisms in the hippocampal neuronal culture model of epilepsy. Cell Calcium30(4), 285–296 (2001).
   PubMedGoogle Scholar
• Pal S, Limbrick DD Jr, Rafiq A, DeLorenzo RJ. Induction of spontaneous recurrent epileptiform discharges causes long-term changes in intracellular calcium homeostatic mechanisms. Cell Calcium28(3), 181–193 (2000).
   PubMed Web of Science ®Google Scholar
• Sherwin AL. Neuroactive amino acids in focally epileptic human brain: a review. Neurochem Res.24(11), 1387–1395 (1999).
   PubMedGoogle Scholar
• Liu Z, Stafstrom CE, Sarkisian MR et al. Seizure-induced glutamate release in mature and immature animals: an in vivo microdialysis study. Neuroreport8(8), 2019–2023 (1997).
   PubMedGoogle Scholar
• Smolders I, Khan GM, Manil J, Ebinger G, Michotte Y. NMDA receptor-mediated pilocarpine-induced seizures: characterization in freely moving rats by microdialysis. Br. J. Pharmacol.121(6), 1171–1179 (1997).
   PubMedGoogle Scholar
• Meldrum BS. First Alfred Meyer Memorial Lecture. Epileptic brain damage: a consequence and a cause of seizures. Neuropathol. Appl. Neurobiol.23(3), 185–201; discussion 201–202 (1997).
   PubMed Web of Science ®Google Scholar
• Rice AC, DeLorenzo RJ. NMDA receptor activation during status epilepticus is required for the development of epilepsy. Brain Res.782(1–2), 240–247 (1998).
   PubMed Web of Science ®Google Scholar
• Hort J, Brozek G, Mares P, Langmeier M, Komarek V. Cognitive functions after pilocarpine-induced status epilepticus: changes during silent period precede appearance of spontaneous recurrent seizures. Epilepsia40(9), 1177–1183 (1999).
   PubMedGoogle Scholar
• Prasad A, Williamson JM, Bertram EH. Phenobarbital and MK-801, but not phenytoin, improve the long-term outcome of status epilepticus. Ann. Neurol.51(2), 175–181 (2002).
   PubMedGoogle Scholar
• Bardo S, Cavazzini MG, Emptage N. The role of the endoplasmic reticulum Ca2+ store in the plasticity of central neurons. Trends Pharmacol. Sci.27(2), 78–84 (2006).
   PubMed Web of Science ®Google Scholar
• Friel D. Interplay between ER Ca2+ uptake and release fluxes in neurons and its impact on [Ca2+] dynamics. Biol Res,37(4), 665–674 (2004).
   PubMedGoogle Scholar
• Lazarewicz JW, Rybkowski W, Sadowski M et al.N-methyl-D-aspartate receptor-mediated, calcium-induced calcium release in rat dentate gyrus/CA4 in vivo. J. Neurosci. Res.51(1), 76–84 (1998).
   PubMedGoogle Scholar
• Jin W, Sugaya A, Tsuda T, Ohguchi H, Sugaya E. Relationship between large conductance calcium-activated potassium channel and bursting activity. Brain Res.860(1–2), 21–28 (2000).
   PubMed Web of Science ®Google Scholar
• Nagarkatti N, Deshpande LS, DeLorenzo RJ. Levetiracetam inhibits both ryanodine and IP3 receptor activated calcium induced calcium release in hippocampal neurons in culture. Neurosci. Lett.436(3), 289–293 (2008).
   PubMedGoogle Scholar
• Cataldi M, Lariccia V, Secondo A, di Renzo G, Annunziato L. The antiepileptic drug levetiracetam decreases the inositol 1,4,5-trisphosphate-dependent [Ca2+]i increase induced by ATP and bradykinin in PC12 cells. J. Pharmacol. Exp. Ther.313(2), 720–730 (2005).
   PubMed Web of Science ®Google Scholar
• Carter DS, Harrison AJ, Falenski KW, Blair RE, DeLorenzo RJ. Long-term decrease in calbindin-D28K expression in the hippocampus of epileptic rats following pilocarpine-induced status epilepticus. Epilepsy Res.79(2–3), 213–223 (2008).
   PubMedGoogle Scholar
• Magloczky Z, Halasz P, Vajda J, Czirjak S, Freund TF. Loss of calbindin-D28K immunoreactivity from dentate granule cells in human temporal lobe epilepsy. Neuroscience76(2), 377–385 (1997).
   PubMedGoogle Scholar
• Nagerl UV, Mody I, Jeub M et al. Surviving granule cells of the sclerotic human hippocampus have reduced Ca2+ influx because of a loss of calbindin-D(28k) in temporal lobe epilepsy. J. Neurosci.20(5), 1831–1836 (2000).
   PubMedGoogle Scholar
• Baimbridge KG, Miller JJ. Hippocampal calcium-binding protein during commissural kindling-induced epileptogenesis: progressive decline and effects of anticonvulsants. Brain Res.324(1), 85–90 (1984).
   PubMedGoogle Scholar
• Shetty AK, Turner DA. Intracerebroventricular kainic acid administration in adult rat alters hippocampal calbindin and non-phosphorylated neurofilament expression. J. Comp. Neurol.363(4), 581–599 (1995).
   PubMedGoogle Scholar
• Lee S, Williamson J, Lothman EW et al. Early induction of mRNA for calbindin-D28k and BDNF but not NT-3 in rat hippocampus after kainic acid treatment. Brain Res. Mol. Brain Res.47(1–2), 183–194 (1997).
   PubMedGoogle Scholar
• Sonnenberg JL, Frantz GD, Lee S et al. Calcium binding protein (calbindin-D28k) and glutamate decarboxylase gene expression after kindling induced seizures. Brain Res. Mol. Brain Res.9(3), 179–190 (1991).
   PubMedGoogle Scholar
• Lowenstein DH, Gwinn RP, Seren MS, Simon RP, McIntosh TK. Increased expression of mRNA encoding calbindin-D28K, the glucose-regulated proteins, or the 72 kDa heat-shock protein in three models of acute CNS injury. Brain Res. Mol. Brain Res.22(1–4), 299–308 (1994).
   PubMedGoogle Scholar
• DeLorenzo RJ. The calmodulin hypothesis of neurotransmission. Cell Calcium2(4), 365–385 (1981).
   PubMedGoogle Scholar
• Blair RE, Sombati S, Churn SB, Delorenzo RJ. Epileptogenesis causes an N-methyl-D-aspartate receptor/Ca2+-dependent decrease in Ca2+/calmodulin-dependent protein kinase II activity in a hippocampal neuronal culture model of spontaneous recurrent epileptiform discharges. Eur. J. Pharmacol.588(1), 64–71 (2008).
   PubMedGoogle Scholar
• Erondu NE, Kennedy MB. Regional distribution of type II Ca2+/calmodulin-dependent protein kinase in rat brain. J. Neurosci.5(12), 3270–3277 (1985).
   PubMed Web of Science ®Google Scholar
• Carter DS, Haider SN, Blair RE et al. Altered calcium/calmodulin kinase II activity changes calcium homeostasis that underlies epileptiform activity in hippocampal neurons in culture. J. Pharmacol. Exp. Ther.319(3), 1021–1031 (2006).
   PubMedGoogle Scholar
• Wasterlain CG, Farber DB. Kindling alters the calcium/calmodulin-dependent phosphorylation of synaptic plasma membrane proteins in rat hippocampus. Proc. Natl Acad. Sci. USA81(4), 1253–1257 (1984).
   PubMedGoogle Scholar
• Yamagata Y, Imoto K, Obata K. A mechanism for the inactivation of Ca2+/calmodulin-dependent protein kinase II during prolonged seizure activity and its consequence after the recovery from seizure activity in rats in vivo. Neuroscience140(3), 981–992 (2006).
   PubMedGoogle Scholar
• Singleton MW, Holbert WH 2nd, Ryan ML et al. Age dependence of pilocarpine-induced status epilepticus and inhibition of CaM kinase II activity in the rat. Brain Res. Dev. Brain Res.156(1), 67–77 (2005).
   PubMedGoogle Scholar
• Churn SB, Sombati S, Jakoi ER, Severt L, DeLorenzo RJ. Inhibition of calcium/calmodulin kinase II α subunit expression results in epileptiform activity in cultured hippocampal neurons. Proc. Natl Acad. Sci. USA97(10), 5604–5609 (2000).
   PubMedGoogle Scholar
• Merrill MA, Chen Y, Strack S, Hell JW. Activity-driven postsynaptic translocation of CaMKII. Trends Pharmacol. Sci.26(12), 645–653 (2005).
   PubMedGoogle Scholar
• Dong Y, Rosenberg HC. Prolonged changes in Ca2+/calmodulin-dependent protein kinase II after a brief pentylenetetrazol seizure; potential role in kindling. Epilepsy Res.58(2–3), 107–117 (2004).
   PubMedGoogle Scholar
• Friel DD, Chiel HJ. Calcium dynamics: analyzing the Ca2+ regulatory network in intact cells. Trends Neurosci.31(1), 8–19 (2008).
   PubMedGoogle Scholar
• Ben-Ari Y. Cell death and synaptic reorganizations produced by seizures. Epilepsia42(Suppl. 3), 5–7 (2001).
   PubMedGoogle Scholar
• Morimoto K, Fahnestock M, Racine RJ. Kindling and status epilepticus models of epilepsy: rewiring the brain. Prog. Neurobiol.73(1), 1–60 (2004).
   PubMed Web of Science ®Google Scholar
• Orrenius S, McCabe MJ Jr, Nicotera P. Ca2+-dependent mechanisms of cytotoxicity and programmed cell death. Toxicol. Lett.64–65 Spec. No, 357–364 (1992).
   Web of Science ®Google Scholar
• Fujikawa DG. Prolonged seizures and cellular injury: understanding the connection. Epilepsy Behav.7(Suppl. 3), S3–S11 (2005).
   Web of Science ®Google Scholar
• Holmes GL. Seizure-induced neuronal injury: animal data. Neurology59(9 Suppl. 5), S3–S6 (2002).
   Google Scholar
• Duncan JS. Seizure-induced neuronal injury: human data. Neurology59(9 Suppl. 5), S15–S20 (2002).
   PubMed Web of Science ®Google Scholar
• Liu RS, Lemieux L, Bell GS et al. Cerebral damage in epilepsy: a population-based longitudinal quantitative MRI study. Epilepsia46(9), 1482–1494 (2005).
   PubMed Web of Science ®Google Scholar
• Pitkanen A, Nissinen J, Nairismagi J et al. Progression of neuronal damage after status epilepticus and during spontaneous seizures in a rat model of temporal lobe epilepsy. Prog. Brain Res.135, 67–83 (2002).
   PubMedGoogle Scholar
• Simpson PB, Challiss RA, Nahorski SR. Neuronal Ca2+ stores: activation and function. Trends Neurosci.18(7), 299–306 (1995).
   PubMedGoogle Scholar
• Sanchez RM, Dai W, Levada RE, Lippman JJ, Jensen FE. AMPA/kainate receptor-mediated downregulation of GABAergic synaptic transmission by calcineurin after seizures in the developing rat brain. J. Neurosci.25(13), 3442–3451 (2005).
   PubMed Web of Science ®Google Scholar
• Deshpande LS, Nagarkatti N, Ziobro JM, Sombati S, Delorenzo RJ. Carisbamate prevents the development and expression of spontaneous recurrent epileptiform discharges and is neuroprotective in cultured hippocampal neurons. Epilepsia49(10), 1795–1802 (2008).
   PubMedGoogle Scholar
• Grabenstatter HL, Dudek FE. A new potential AED, carisbamate, substantially reduces spontaneous motor seizures in rats with kainate-induced epilepsy. Epilepsia49(10), 1787–1794 (2008).
   PubMed Web of Science ®Google Scholar
• Deshpande LS, Nagarkatti N, Sombati S, DeLorenzo RJ. The novel antiepileptic drug carisbamate (RWJ 333369) is effective in inhibiting spontaneous recurrent seizure discharges and blocking sustained repetitive firing in cultured hippocampal neurons. Epilepsy Res.79(2–3), 158–165 (2008).
   PubMed Web of Science ®Google Scholar
• Pitkanen A, Lukasiuk K. Molecular and cellular basis of epileptogenesis in symptomatic epilepsy. Epilepsy Behav.14(Suppl. 1), 16–25 (2009).
   PubMedGoogle Scholar
• Pisani A, Bonsi P, Martella G et al. Intracellular calcium increase in epileptiform activity: modulation by levetiracetam and lamotrigine. Epilepsia45(7), 719–728 (2004).
   PubMed Web of Science ®Google Scholar
• Kulak W, Sobaniec W, Wojtal K, Czuczwar SJ. Calcium modulation in epilepsy. Pol. J. Pharmacol.56(1), 29–41 (2004).
   PubMedGoogle Scholar
• Brandt C, Potschka H, Loscher W, Ebert U. N-methyl-D-aspartate receptor blockade after status epilepticus protects against limbic brain damage but not against epilepsy in the kainate model of temporal lobe epilepsy. Neuroscience118(3), 727–740 (2003).
   PubMed Web of Science ®Google Scholar
• Loscher W. Animal models of epilepsy for the development of antiepileptogenic and disease-modifying drugs. A comparison of the pharmacology of kindling and post-status epilepticus models of temporal lobe epilepsy. Epilepsy Res.50(1–2), 105–123 (2002).
   PubMed Web of Science ®Google Scholar
• Rogawski MA, Wenk GL. The neuropharmacological basis for the use of memantine in the treatment of Alzheimer’s disease. CNS Drug Rev.9(3), 275–308 (2003).
   PubMedGoogle Scholar
• Rice AC, DeLorenzo RJ. N-methyl-D-aspartate receptor activation regulates refractoriness of status epilepticus to diazepam. Neuroscience93(1), 117–123 (1999).
   PubMed Web of Science ®Google Scholar